Erythropoietin (EPO) was originally used to promote red blood cell production and treat anemia.[5] Animal experiments showed that erythropoietin and its receptors are expressed in the central nervous system, and that erythropoietin could pass through the blood-cerebrospinal fluid barrier of many animals to play a protective role in the nervous system. The gene discussed is EPO; the disease is anemia (phenotype).